2009
DOI: 10.3174/ajnr.a1495
|View full text |Cite
|
Sign up to set email alerts
|

Sodium MR Imaging Detection of Mild Alzheimer Disease: Preliminary Study

Abstract: BACKGROUND AND PURPOSE:There is significant interest in the development of novel noninvasive techniques for the diagnosis of Alzheimer disease (AD) and tracking its progression. Because MR imaging has detected alterations in sodium levels that correlate with cell death in stroke, we hypothesized that there would be alterations of sodium levels in the brains of patients with AD, related to AD cell death.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
82
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 102 publications
(90 citation statements)
references
References 60 publications
5
82
0
Order By: Relevance
“…The potential diagnostic benefits of 23 Na-MR imaging have recently been demonstrated for common pathological conditions such as tumor [5,6], stroke [7][8][9], Alzheimer disease [10], paramyotonia [11], arthritis [12], multiple sclerosis [13] and functional renal imaging [14] in humans. In addition, pre-clinical in vivo 23 Na MRI enables one to temporally follow pathological progression in animal models of common human disease [14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…The potential diagnostic benefits of 23 Na-MR imaging have recently been demonstrated for common pathological conditions such as tumor [5,6], stroke [7][8][9], Alzheimer disease [10], paramyotonia [11], arthritis [12], multiple sclerosis [13] and functional renal imaging [14] in humans. In addition, pre-clinical in vivo 23 Na MRI enables one to temporally follow pathological progression in animal models of common human disease [14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…Other MR imaging techniques, such as sodium MR imaging, can detect differences between a patient with mild AD and controls, which correlate with hippocampal volume. 80 While these methods hold promise, unlike hippocampal atrophy on structural MR imaging, none are yet recognized or validated as an AD biomarker for the purposes of diagnosis or clinical trials.…”
Section: Discussionmentioning
confidence: 99%
“…The IVF and TCF bioscales inform on cell packing and cell density which have been shown to be informative in clinical settings of tissue viability in stroke (Thulborn et al, 1999;Boada et al, 2005) and brain tumor response to radiation and chemotherapy (Thulborn et al, accepted for publication; Kline et al, 2000). Current investigations suggest that the TSC, IVF, and TCF bioscales may reflect regional changes in sodium concentration in early neurodegenerative diseases (Mellon et al, 2009;.…”
Section: Introductionmentioning
confidence: 96%